Targeted Protein Degradation as an Antiviral Strategy

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

We currently do not have effective vaccines or antiviral drugs for most of the viral diseases that afflict humans.  Antiviral therapies that enable long-term control over human immunodeficiency virus (HIV) infection and cure chronic hepatitis C virus (HCV) have been landmark successes in the treatment of viral infections.  These therapies work through the use of multiple direct-acting antiviral (DAA) drugs that act by potently inhibiting the function of viral proteins, generally enzymes such as viral polymerases and proteases. Narrow spectrum activity (i.e., the “one bug, one drug” problem) and drug resistance are two major challenges for the antivirals field.  This is especially true against viruses with RNA genomes because limited or no proofreading function of the viral polymerase generates tremendous genetic diversity.  There is thus a need for antiviral strategies that make use of alternative targets, mechanisms, and modalities to combat viral diseases and to avoid antiviral resistance.  My group has focused on the discovery and validation of new antiviral targets and strategies. Here I hope to provide to examples of our proof-of-concept work establishing targeted protein degradation as an alternative antiviral strategy.

 

Learning objectives:

1. Understand the mechanism of what a degrader (also known as PROTAC, “degronimid”) is.

2.  Understand how one experimentally determines if a small molecule has a “degrader” mechanism.

3. Explain potential advantages of degraders versus conventional inhibitors as direct-acting antivirals.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JUN 08, 2021 9:00 AM PDT
JUN 08, 2021 9:00 AM PDT
Date: June 8, 2021 Time: 9:00am PDT Reducing the spread of highly infectious and deadly diseases within the population, vaccine development is crucial in saving millions of lives each year....
Loading Comments...
Show Resources